Over-expression of NF-κB has been reported to be associated with poorer prognosis in NPC102, 103 and therefore supporting the rational of exploiting NF-κB inhibitor as potential treatment strategy for NPC. This evidence concerns the gene NFKB1 and nasopharyngeal carcinoma.